Biohaven Ltd. (BHVN)

NYQ – Цена в реальном времени. Валюта: USD

14.29

-0.20 (-1.38%)

Рынок открыт: Aug 12, 2026, 3:15 PM EDT

14.21

-0.28 (-1.93%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

10.08.2026

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

First extracellular protein degraders in the clinic demonstrate rapid and robust pharmacodynamic effects and compelling safety in nearly 200 individuals dosed, Phase 3 trial underway Positive clinical biomarker and patient data presented from Biohaven's extracellular degrader platform demonstrated deep, rapid, selective lowering of disease-driving antibodies with BHV-1300 in Graves' disease and BHV-1400 IgA Nephropathy, supporting advancement toward multiple registrational programs. Initiated pivotal Phase 3 study for BHV-1300 in Graves' disease with plans to initiate pivotal Phase 3 study for BHV-1400 in IgAN in 2H 2026.

06.08.2026

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Infinitum founder and Groq board director brings frontier AI and technology-investing expertise to Biohaven as the company advances AI-enabled approaches to drug development NEW HAVEN, Conn., Aug. 6, 2026 /PRNewswire/ -- Biohaven Ltd.

Видео

No Data

There is no data to display

Пресс-релизы

10.08.2026

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

06.08.2026

Biohaven Ltd. (BHVN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Biohaven Ltd. (BHVN)

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Видео

No Data

Пресс-релизы

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Видео

No Data

Пресс-релизы

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Search stocks

Biohaven Ltd. (BHVN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Biohaven Ltd. (BHVN)

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Видео

No Data

Пресс-релизы

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors

Видео

No Data

Пресс-релизы

Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results

Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors